MDxHealth partnered with Pfizer, Cancer Research Technology (CRT) and the University of Newcastle to develop a biomarker to predict a patient's response to Pfizer PF-01367338

MDxHealth S.A.

Belgium / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Pfizer Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cancer Research Technology Ltd.

U.K. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

University of Newcastle

Australia / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced